DryEye Rescue has announced its exclusive distribution rights for ScoutPro in the U.S., enhancing access to advanced dry eye diagnostics for medical practices.

Robinson Pharma, Inc. receives the prestigious 'Above and Beyond' Supplier Award from Bausch + Lomb for exceptional performance in 2026.

Bausch Health's Thomas J. Appio joins the board of Bausch + Lomb, aiming to bolster its long-term growth strategy for shareholders.

Bausch + Lomb's investors are invited to participate in a legal investigation regarding possible securities law violations, led by the Schall Law Firm. Details inside.

The Pomerantz Law Firm is examining potential securities fraud claims against Bausch + Lomb following significant stock drops related to product recalls and financial losses.

Pomerantz Law Firm is scrutinizing Bausch + Lomb as investors face potential losses. The firm investigates recent recalls and financial downturn.

Pomerantz LLP is probing into Bausch + Lomb for possible fraud. This comes after significant product recalls and financial losses reported by the company.

The Pomerantz Law Firm is actively investigating investor claims against Bausch + Lomb Corporation following a series of troubling disclosures.

Pomerantz LLP is scrutinizing allegations concerning Bausch + Lomb Corporation after recent financial setbacks and safety recalls, impacting investor trust.